Poddar Richa 4
4 · AGIOS PHARMACEUTICALS, INC. · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Poddar Richa
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock
2022-02-10+2,068→ 2,218 total - Exercise/Conversion
Restricted stock units
2022-02-10−2,068→ 4,136 total→ Common stock (2,068 underlying) - Tax Payment
Common stock
2022-02-10$31.43/sh−725$22,783→ 1,493 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.